Now a cholesterol pill to cut down the risk of a heart attack? New study reveals ‘hopeful’ results
etimes.in / Jun 16, 2025, 14:06 (IST)
A groundbreaking daily pill, Obicetrapib, shows promise in managing high cholesterol, potentially reducing heart attack and stroke risks. A Monash University trial revealed that Obicetrapib significantly lowered LDL cholesterol by 32.6% and lipoprotein(a) by 33.5% in participants already on maximum tolerated doses of traditional therapies.